| TIZIANA LIFE SCIENCES LTD |
| Hong Kong (China) |
| Gesundheit |
| BMG889121031 / A3C5SS |
| 0RP (Frankfurt) / TLSA (NASDAQ) |
| FRA:0RP, ETR:0RP, 0RP:GR, NASDAQ:TLSA |
| - |
| https://www.tizianalifesc.. |
|
Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company focused on developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Headquartered in London and founded in 2013, the company specializes in alternat..
>Volltext.. |
| 107.67 Mio. EUR |
| 104.58 Mio. EUR |
| - |
| -18.25 Mio. EUR |
| -15.98 Mio. EUR |
| -0.14 EUR |
| 0.4 Mio. EUR |
| 3.48 Mio. EUR |
| -11.14 Mio. EUR |
| 0.36 |
| - |
| -55.37% |
| - |
| - |
| - |
| TIZIANA |
| 07.08.26 |
|
||||
|
||||
|
||||
|